Connect with us

Technology

Dyslexia Treatment Market Size to hit $11.74 billion by 2031, growing at a CAGR of 6.4%, says Coherent Market Insights

Published

on

BURLINGAME, Calif., July 22, 2024 /PRNewswire/ — The global Dyslexia Treatment Market is projected to grow from USD 7.59 billion in 2024 to USD 11.74 billion by 2031, with a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031, as per a recent report by Coherent Market Insights. Increasing understanding about learning difficulties like dyslexia, more parents are understanding the need for specialized treatment options. Various non-profit organizations and advocacy groups are promoting screening and early detection of dyslexia in schools. Their efforts are helping identify students who need support and accommodation.

Get Sample Pages: https://www.coherentmarketinsights.com/insight/request-sample/7002

Market Dynamics: 

The dyslexia treatment market is driven by growing awareness regarding early dyslexia diagnosis and treatment. Various initiatives undertaken by governments and non-profit organizations to educate people about dyslexia symptoms and available treatment options are also expected to aid market growth. Additionally, the introduction of novel screening and assessment tools for identifying dyslexia at an early stage is estimated to present lucrative opportunities. However, the high cost of specialized dyslexia treatment and diagnosis is expected to hinder the market growth.

Dyslexia Treatment Market Report Coverage

Report Coverage

Details

Market Revenue in 2024

$7.59 billion

Estimated Value by 2031

$11.74 billion

Growth Rate

Poised to grow at a CAGR of 6.4%

Historical Data

2019–2023

Forecast Period

2024–2031

Forecast Units

Value (USD Million/Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Type, By Drug Class, By Distribution Channel

Geographies Covered

North America, Europe, Asia Pacific, and Rest of World

Growth Drivers

 

Increasing Research and Development Activities by Key Market Players Growing Awareness and Social Acceptance of Dyslexia

Restraints & Challenges

 

Lack of Trained Professionals Social Stigma

Market Trends:

Audio-visual stimulation therapy and brain training programs have gained immense popularity in recent years. Many clinics and schools are implementing specialized programs that involve the use of technology such as audio books, music therapy, and computer-assisted reading programs to aid dyslexic children. Neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) are also emerging as promising treatment avenues. rTMS involves using magnetic fields to stimulate targeted areas of the brain and help reorganize dysfunctional neural connections related to reading, writing and language processing in dyslexia patients.

Market Opportunities:

Phonological dyslexia is the most common type of dyslexia. It occurs due to impaired ability to relate sounds to letters. Around 75% of people with dyslexia have phonological dyslexia. The increasing awareness campaigns by non-profit organizations are highlighting this fact and driving more people towards seeking effective treatment options for phonological dyslexia. Various methods such as Orton-Gillingham and Lindamood Bell programs focus on phonological awareness, letter-sound association and decodable texts. The growth in personalized therapies and digital learning tools for phonics-based reading is expected to provide lucrative opportunities in this segment.

Immediate Delivery Available | Buy This Premium Research Report:
https://www.coherentmarketinsights.com/insight/buy-now/7002 

With advancements in digital health technologies, home care delivery models for dyslexia treatment are gaining popularity. Products like speech recognition software, audio books, apps for testing & remediation are easy to access from home and provide flexible options for users. They are finding wide acceptance for supporting independent learning, continued practice and screening of dyslexia symptoms. This reduces the burden on hospitals and clinics. Specialized home care service providers are emerging who offer teletherapy, online tutoring and mentoring for dyslexic individuals. The comfort, affordability and growing remote care trend is driving the demand in the home care segment.

Key Market Takeaways

The global dyslexia treatment market size was valued at USD 7.59 billion in 2024 and is anticipated to witness a CAGR of 6.4% during the forecast period. Increasing public awareness about dyslexia diagnosis and availability of various rehabilitation options are fueling the market growth.

By type, phonological dyslexia segment holds the largest share owing to its high prevalence rate. Phonics-based therapies are very effective for this type of dyslexia.

On the basis of end users, specialty centers segment dominates the market due to availability of dedicated dyslexia specialists and multidisciplinary treatment approaches under one roof.

North America has emerged as the leading regional market on account of established healthcare infrastructure and favorable government policies for learning disabilities in the US and Canada.

Key players operating in this space include Pfizer, Inc., Speechify Inc., and Jubilant Pharma Limited among others. These companies are focusing on new product launches and geographical expansion to strengthen their market position.

Recent Developments:

In December 2022, The All-India Institute of Medical Sciences (AIIMS) announced the development of an app to help cure dyslexia in children. This app, being made under AIIMS Pediatric Neurology Dyslexia Remedial Intervention Program that has eight modules will allow dyslexia treatment to be done sitting at home.

In August 2021, An Australian ed-tech start-up named Dystech, has created a dyslexia screening tool for the early identification of learning disabilities and has raised $290K to advance the development of its Dyscover platform and make it accessible to schools and allied health professionals around the world.

To conclude, the dyslexia treatment market offers promising prospects backed by ongoing research on innovative drugs and technologies. Increasing collaborations between industry and non-profits augur well for the industry.

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/7002

Detailed Segmentation-

By Type:

Phonological DyslexiaSurface DyslexiaDouble Deficit DyslexiaOthers

By Drug Class:

AntihistaminesCentral Nervous StimulantSelective Norepinephrine Reuptake InhibitorsOthers

By Distribution Channel:

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

By Region:

North America:

U.S.Canada

Latin America:

BrazilArgentinaMexicoRest of Latin America

Europe:

GermanyU.K.SpainFranceItalyRussiaRest of Europe

Asia Pacific:

ChinaIndiaJapanAustraliaSouth KoreaASEANRest of Asia Pacific

Middle East:

GCC CountriesIsraelRest of Middle East

Africa:

South AfricaNorth AfricaCentral Africa

Browse More Trending Reports:

Global Geriatric Medicines Market: Global geriatric medicines market is estimated to be valued at USD 1,004.71 Bn in 2024 and is expected to reach USD 1,570.18 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

Vinpocetine Supplements Market: The vinpocetine supplements market is estimated to be valued at USD 281.4 Mn in 2024 and is expected to reach USD 373.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.

Eyelash Serum Market: The eyelash serum market is estimated to be valued at USD 936.3 Mn in 2024 and is expected to reach USD 1,365.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

Multi Dose Drug Vial Adapters Market: The multi dose drug vial adapters market is estimated to be valued at USD 1,104.1 Mn in 2024 and is expected to reach USD 1,765.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone: 
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Photo: https://mma.prnewswire.com/media/2466241/Dyslexia_Treatment_Market.jpg
Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/dyslexia-treatment-market-size-to-hit-11-74-billion-by-2031–growing-at-a-cagr-of-6-4-says-coherent-market-insights-302202909.html

SOURCE Coherent Market Insights

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BlueNexus Technologies Unveils AquaX Hub at SIWW 2026 — AI Autonomous Operations Extended to Legacy Water Assets

Published

on

By

SINGAPORE, June 21, 2026 /PRNewswire/ — At Singapore International Water Week (SIWW) 2026, BlueNexus Technologies unveiled the global debut of AquaX Hub™ — a compact plug-and-play edge device that brings full AI-powered autonomous operation to standalone water equipment and legacy treatment plants. The launch drew sustained engagement from utilities, industrial operators and engineering firms.

The water sector confronts converging pressures: aging infrastructure, a critical shortage of skilled technicians, and relentless operational cost escalation. AquaX Hub™ answers these directly — extending the AI autonomous operation already proven plant-wide by AquaX Robot™ to a single asset, and delivering comparable monitoring and operational management without a control-system overhaul.

“The industry cannot hire its way out of this problem,” said Jack Zhang, CEO of BlueNexus Technologies. “AI autonomous operation is no longer a future concept — the barrier to entry is gone.”

The AquaX Ecosystem

BlueNexus has built the industry’s first fully integrated AI autonomous water operation platform, spanning three complementary pillars:

AquaX Robot™ is the flagship plant-wide AI agent, built on large language models with proprietary vision, acoustic and infrared multimodal sensing. It optimizes treatment processes 24/7 and predicts equipment failures. Live deployments show up to 90% reduction in on-site staffing, a 50% drop in equipment breakdowns, and approximately 35% lower O&M costs.

AquaX Hub™, making its global debut at SIWW 2026, is a lightweight edge terminal extending that capability to any water system. With an independent local processing module, it monitors and inspects equipment through multimodal sensing and runs a self-contained processing loop. The device integrates seamlessly with existing SCADA, cloud and enterprise platforms via standardized APIs.

i-WaterHub™, the company’s standardized modular treatment plant, operated autonomously by AquaX Robot, delivers 2,500 to 40,000 m³/day for municipal and industrial applications.

Market Momentum

SIWW 2026 convened nearly 500 exhibitors from over 65 countries. BlueNexus has identified priority markets for AquaX Hub™ in Southeast Asia, the Middle East and Africa. “The conversations this week have already translated into concrete business opportunities and we expect rapid deployment in the coming months.” Zhang confirmed.

About BlueNexus Technologies

BlueNexus Technologies is a Singapore-based water-technology company building intelligent, AI-operated systems for the world’s most water-intensive industries. We design and deliver modular water treatment infrastructure that is smarter to run, faster to deploy, and built to operate autonomously.

Web: www.bluenexus.tech

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bluenexus-technologies-unveils-aquax-hub-at-siww-2026–ai-autonomous-operations-extended-to-legacy-water-assets-302805849.html

SOURCE BlueNexus Technologies

Continue Reading

Technology

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS

Published

on

By

With the presence of Emmanuel Macron and Narendra Modi, Prime Minister of India

PARIS, June 20, 2026 /CNW/ — From June 17 to 20, 2026 at Paris Porte de Versailles, VivaTech celebrated its 10th edition, surpassing the exceptional milestone of 200,000 visitors from 165 nationalities, with more than 15,000 startups present, 1,155 speakers and over 5 billion cumulative impressions on social media. Europe’s largest tech and innovation event has reached a new dimension, consolidating its status as an unmissable global gathering.

Exceptional speakers

VivaTech welcomed the greatest figures in global tech: Jeff Bezos (Amazon & Blue Origin), Dave Limp (Blue Origin), Bernard Arnault (LVMH), Henna Virkkunen (European Commission), Ekaterina Zaharieva (European Commission). Germany, Country of the Year 2026, was represented by a ministerial delegation, while India, AI Country Partner 2026, was led by Prime Minister Narendra Modi, as a continuation of the AI Summit in New Delhi.

Innovation and business at the heart of the event

More than 4,500 exhibitors, 61% of whom were international, showcased their latest innovations. Among the standout innovations: the smart contact lens by XPANCEO, the thought-controlled humanoid robot by Unitree x HABS, and the 3D-printed resorbable implants by Lattice Medical. New formats such as the Business Plaza and Investors Office Hours further accelerated business connections.

The VivaTech x Bloomberg Awards

For the first time, VivaTech presented the VivaTech x Bloomberg Awards, recognising the most influential figures in global tech, including Sir Tim Berners-Lee (Visionary Award), Joe Tsai (Leadership Award) and Yann LeCun (Momentum Award).

Innovation open to all

VivaTech also took over the Champs-Élysées on June 14th for an open-air technology showcase, before opening its doors to the general public on June 20th with astronaut Thomas Pesquet as guest star.

“This 10th edition was not a celebration of the 9 previous years, but the opening of a new decade full of promise.” — Maurice Lévy, Michèle Benbunan & François Bitouzet, VivaTech

See you from June 16 to 19, 2027 at Paris Expo Porte de Versailles for VivaTech 2027!

About VivaTech

VivaTech accelerates innovation by connecting startups, tech leaders, major companies, and investors responding to our world’s biggest challenges.  

Each year, over four exciting days in Paris, VivaTech creates Europe’s biggest startup and tech event, exploring the most disruptive topics in tech with world-premiere demos, launches, and conferences in a collaborative ecosystem. This is where business meets innovation. Join us for the eleventh edition of VivaTech 16-19 June 2027.

For more information go to our website at https://vivatech.com/media or follow us on social media @VivaTech.

Contact
press@vivatechnology.com 

Logo: https://mmx.prnewswire.com/media/MS1865564/VT_LOGO_EN.jpg
Photo : https://mmx.prnewswire.com/media/MS1869778/VivaTech_2026.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/vivatech-2026-celebrates-its-10th-anniversary-with-a-record-edition-surpassing-200-000-visitors-302805827.html

SOURCE VivaTech

Continue Reading

Technology

Pope Leo XIV embraces paediatric patients at CNAO in Pavia

Published

on

By

PAVIA, Italy, June 20, 2026 /PRNewswire/ — The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV’s pastoral visit to the city of Pavia. His choice to begin his journey at this center reflects a profound commitment to fostering meaningful dialogue between advanced scientific progress and the alleviation of human suffering.

CNAO President Gianluca Vago and General Manager Sandro Rossi received His Holiness, illustrating the center’s distinctive capabilities. CNAO stands out as a unique reality in Italy, remaining one of the very few facilities worldwide capable of delivering hadrontherapy using both protons and carbon ions. The technological core of the facility is its synchrotron, a subatomic particle accelerator that generates ultra-high-precision beams to treat complex, inoperable and radioresistant tumours. This cutting-edge technology allows for the targeted eradication of diseased cells while meticulously preserving surrounding healthy tissues, drastically improving patients’ survival and quality of life.

Furthermore, CNAO is expanding its capabilities as a premier multi-center utilizing new ion species, like Helium, later Oxygen and Neon. Soon, treatments will incorporate the Leo Cancer Care upright positioning and imaging system. The immediate future also includes beginning therapies with a Hitachi dedicated proton accelerator and gantry and a BNCT system for metastatic diseases, equipped with an electrostatic accelerator produced by TAE Life Science. With these new technologies, CNAO will become one of the most technologically advanced center in the world.

To date, over six thousand individuals, including approximately three hundred children and adolescents, have benefited from these life-saving treatments.

During his visit, the Pope engaged with CNAO’s Board of Directors, a collaborative body uniting national universities, clinical institutions, and research centers. He also extended his heartfelt greetings to the two hundred employees of the center. These doctors, physicists, engineers, and researchers tirelessly operate the advanced technologies in the service of oncology patients.

The emotional pinnacle of the day was the Holy Father’s private gathering with a delegation of young children who underwent treatment. The paediatric patients and their families shared a deeply touching moment of closeness, receiving the Pope’s comforting embrace.

“The visit of Pope Leo XIV honours us and represents a moment of extraordinary human value”, stated CNAO President Gianluca Vago. “In his encyclical Magnifica Humanitas, the Holy Father emphasizes the necessity of a science that constantly safeguards the centrality of the person and directs technology toward the common good. In a time marked by global tensions, CNAO testifies daily how the incredible power of the atom can be used not to destroy, but to heal. The particle beams we utilize against disease are, symbolically, Rays of Hope, sharing and supporting the IAEA project bearing this name. The embrace the Holy Father reserved for our children reminds us that scientific research finds its most authentic purpose when it encounters listening, compassion, and hope”.

Photo – https://mma.prnewswire.com/media/2997869/Papa_al_Cnao_crediti_Andrea_Perotti.jpg
Logo – https://mma.prnewswire.com/media/2997643/CNAO_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/pope-leo-xiv-embraces-paediatric-patients-at-cnao-in-pavia-302805799.html

Continue Reading

Trending